A- A A+

The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment.

Shams I, Sanger N, Bhatt M, Rosic T, Luo C, Shahid H, Mouravska N, Tam SL, Hillmer A, Chawar C, D'Elia A, Hudson J, Marsh D, Thabane L, Samaan Z.

BJPsych Open. 2019 Oct 18;5(6):e91. doi: 10.1192/bjo.2019.78.

https://www.cambridge.org/core/journals/bjpsych-open/article/association-between-health-conditions-and-cannabis-use-in-patients-with-opioid-use-disorder-receiving-methadone-maintenance-treatment

A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment.

Yee A, Loh HS, Loh HH, Riahi S, Ng CG, Sulaiman AHB.

Ann Gen Psychiatry. 2019 Oct 22;18:25. doi: 10.1186/s12991-019-0249-z. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805364/

Opioids and their endocrine effects: A systematic review and meta-analysis.

de Vries F, Bruin M, Lobatto DJ, Dekkers OM, Schoones JW, van Furth WR, Pereira AM, Karavitaki N, Biermasz NR, Zamanipoor Najafabadi AH.

J Clin Endocrinol Metab. 2019 Sep 12. pii: dgz022. doi: 10.1210/clinem/dgz022.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31511863

Methadone poisonings: a seven year retrospective study of the French Poison Centers Network focusing on suicide attempts versus misuses.

Torrents R, Glaizal M, Sinno-Tellier S, Richard N, Nisse P, Vodovar D, Bloch J, Simon N, de Haro L.

Fundam Clin Pharmacol. 2019 Sep 9. doi: 10.1111/fcp.12506.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31498916

Acute Experimental Pain Responses in Methadone- and Buprenorphine/Naloxone-Maintained Patients Administered Additional Opioid or Gabapentin: A Double-Blind Crossover Pilot Study.

Murnion BP, Rivas C, Demirkol A, Hayes V, Lintzeris N, Nielsen S.

Pain Med. 2019 Aug 24. pii: pnz178. doi: 10.1093/pm/pnz178.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31504868

Correlation between interleukin-6 levels and methadone maintenance therapy outcomes.

Lu RB, Wang TY, Lee SY, Chen SL, Chang YH, See Chen P, Lin SH, Chu CH, Huang SY, Tzeng NS, Lee IH, Chin Chen K, Kuang Yang Y, Chen P, Chen SH, Hong JS.

Drug Alcohol Depend. 2019 Aug 30;204:107516. doi: 10.1016/j.drugalcdep.2019.06.018. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31513981

Testing a Neuro-Evolutionary Theory of Social Bonds and Addiction: Methadone Associated With Lower Attachment Anxiety, Comfort With Closeness, and Proximity Maintenance.

Torres N.

Front Psychiatry. 2019 Sep 6;10:602. doi: 10.3389/fpsyt.2019.00602. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743610/

Anästhesievorbereitung: Welche Medikamente vor einer Narkose abgesetzt werden sollten

Schreiner, Mathias J.; Kehl, Franz

Dtsch Arztebl 2019; 116(31-32): A-1428 / B-1183 / C-1167

https://www.aerzteblatt.de/archiv/209139/Anaesthesievorbereitung-Welche-Medikamente-vor-einer-Narkose-abgesetzt-werden-sollten

Early Diagnosis of Hearing Loss in Patients Under Methadone Maintenance Treatment.

Bayat A, Saki N, Mirmomeni G, Yadollahpour A.

Front Neurol. 2019 Jul 16;10:749. doi: 10.3389/fneur.2019.00749. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646465/

Dose Tapering Strategy for Heroin Abstinence among Methadone Maintenance Treatment Participants: Evidence from A Retrospective Study in Guangdong, China.

Lu Q, Zou X, Liu Y, Gong C, Ling L.

Int J Environ Res Public Health. 2019 Aug 6;16(15). pii: E2800. doi: 10.3390/ijerph16152800.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695604/

Frequent nightmares in Chinese patients undergoing methadone maintenance therapy: prevalence, correlates, and their association with functional impairment.

Zhong BL, Xu YM, Xie WX, Lu J.

Neuropsychiatr Dis Treat. 2019 Jul 18;15:2063-2072. doi: 10.2147/NDT.S202813. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646172/

Efficacy of Electroacupuncture Combined with Methadone Maintenance Therapy: A Case-Control Study.

Chen YL, Lee TC, Chen YT, Lo LC, Hsu WY, Ouyang WC.

Evid Based Complement Alternat Med. 2019 Jul 21;2019:7032581. doi: 10.1155/2019/7032581. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699302/

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids.

Makunts T, U A, Atayee RS, Abagyan R.

Sci Rep. 2019 Aug 28;9(1):12490. doi: 10.1038/s41598-019-48955-y.

https://www.nature.com/articles/s41598-019-48955-y

Tramadol könnte Hypoglykämien auslösen

San Diego – Das Schmerzmittel Tramadol, das zunehmend als sichere Alternative zu anderen Opioiden betrachtet wird, kann offenbar schwere Hypoglykämien auslösen. Dies kam in einer Analyse von Datenbanken der US-Arzneimittelbehörde FDA in Scientific Reports(2019; 9: 12490) heraus. (aerzteblatt.de, 29.08.2019)

https://www.aerzteblatt.de/nachrichten/105626/Tramadol-koennte-Hypoglykaemien-ausloesen

Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.

Terasaki D, Smith C, Calcaterra SL.

Pharmacotherapy. 2019 Jul 26. doi: 10.1002/phar.2313.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31348544

Specificity of personality relationships to particular forms of concurrent substance use among methadone maintenance therapy clients.

Mahu IT, Conrod PJ, Barrett SP, Sako A, Swansburg J, Lawrence M, Laroque F, Morin JF, Chinneck A, Nogueira-Arjona R, Stewart SH.

Addict Behav. 2019 Jul 17;98:106056. doi: 10.1016/j.addbeh.2019.106056.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31351326

Decreased Level of Blood MicroRNA-133b in Men with Opioid Use Disorder on Methadone Maintenance Therapy.

Hsu CW, Huang TL, Tsai MC.

J Clin Med. 2019 Jul 25;8(8). pii: E1105. doi: 10.3390/jcm8081105.

https://www.mdpi.com/2077-0383/8/8/1105

Comparing the Effects of Methadone, Buprenorphine, and Opium Tincture Maintenance Therapy on Sexual Function.

Kheradmand A, Fazeli A, Mazaheri Meybodi A.

Addict Health. 2019 Apr;11(2):120-128. doi: 10.22122/ahj.v11i2.232.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633070/

Effectiveness of Mindfulness-based Relapse Prevention on Quality of Life and Craving in Methadone-treated Patients: A Randomized Clinical Trial.

Yaghubi M, Zargar F.

Addict Health. 2018 Oct;10(4):250-259. doi: 10.22122/ahj.v10i4.573.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593172/

Exploring the Effects of Vitamin D Supplementation on Cognitive Functions and Mental Health Status in Subjects Under Methadone Maintenance Treatment.

Ghaderi A, Rasouli-Azad M, Farhadi MH, Mirhosseini N, Motmaen M, Pishyareh E, Omidi A, Asemi Z.

J Addict Med. 2019 May 24. doi: 10.1097/ADM.0000000000000550. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31145174

Cigarette Smoking Is Significantly Linked to Sexual Dissatisfaction in Chinese Heroin-Dependent Patients Receiving Methadone Maintenance Treatment.

Zhong BL, Xu YM, Xie WX, Lu J.

Front Psychiatry. 2019 May 22;10:306. doi: 10.3389/fpsyt.2019.00306.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538806/

Loneliness and Illicit Opioid Use Among Methadone Maintenance Treatment Patients.

Polenick CA, Cotton BP, Bryson WC, Birditt KS.

Subst Use Misuse. 2019 Jun 24:1-10. doi: 10.1080/10826084.2019.1628276. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31232142

Functional Correlates of Resting-State Connectivity in the Default Mode Network of Heroin Users on Methadone Treatment and Medication-Free Therapeutic Community Program.

Kuo LW, Lin PS, Lin SY, Liu MF, Jan H, Lee HC, Wang SC.

Front Psychiatry. 2019 Jun 6;10:381. doi: 10.3389/fpsyt.2019.00381. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562277/

Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use.

Carroll KM, DeVito EE, Yip SW, Nich C, Sofuoglu M.

Am J Addict. 2019 Jun 4. doi: 10.1111/ajad.12904.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31165574

Ginseng treatment improves the sexual side effects of methadone maintenance treatment.

Farnia V, Alikhani M, Ebrahimi A, Golshani S, Sadeghi Bahmani D, Brand S.

Psychiatry Res. 2019 May 2;276:142-150. doi: 10.1016/j.psychres.2019.05.004. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31082749

Comparison of Sexual Function and Serum Testosterone Levels in Men Opiate Addicts, under Methadone Maintenance Therapy, and Healthy Men.

Agha-Mohammadhasani P, Mokhtaree M, Nazari A, Rahnama A.

Addict Health. 2018 Apr;10(2):76-85. doi: 10.22122/ahj.v10i2.540.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494984/

Craving for heroin: difference between methadone maintenance therapy patients with and without ADHD.

Coppola M, Sacchetto G, Mondola R.

Trends Psychiatry Psychother. 2019 Jan-Mar;41(1):83-86. doi: 10.1590/2237-6089-2017-0159.

http://www.scielo.br/pdf/trends/v41n1/2238-0019-trends-41-01-0083.pdf

Characterization of the Safety and Pharmacokinetic Profile of D-Methadone, a Novel N-Methyl-D-Aspartate Receptor Antagonist in Healthy, Opioid-Naive Subjects: Results of Two Phase 1 Studies.

Bernstein G, Davis K, Mills C, Wang L, McDonnell M, Oldenhof J, Inturrisi C, Manfredi PL, Vitolo OV.

J Clin Psychopharmacol. 2019 May/Jun;39(3):226-237. doi: 10.1097/JCP.0000000000001035.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30939592

Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.

Ward HB, Barnett BS, Suzuki J.

Subst Abus. 2019 Mar 19:1-6. doi: 10.1080/08897077.2019.1573776.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30888254

Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.

Victorri-Vigneau C, Verstuyft C, Bouquié R, Laforgue EJ, Hardouin JB, Leboucher J, Le Geay B, Dano C, Challet-Bouju G, Grall-Bronnec M.

Br J Clin Pharmacol. 2019 Mar 25. doi: 10.1111/bcp.13936. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30907440